LYMPHOMA, B-CELL MARGINAL ZONE
Clinical trials for LYMPHOMA, B-CELL MARGINAL ZONE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL MARGINAL ZONE trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets tough blood cancers after standard treatments fail
Disease control OngoingThis early-stage study is testing the safety and initial effectiveness of a new oral drug called LOXO-338 for patients with advanced blood cancers like leukemia and lymphoma who have already received standard therapies. The trial has two parts: first testing LOXO-338 alone, and t…
Matched conditions: LYMPHOMA, B-CELL MARGINAL ZONE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Gentler combo therapy tested for rare lymphoma
Disease control OngoingThis study is testing a new first treatment for early-stage MALT lymphoma, a type of slow-growing cancer. It combines a targeted drug (orelabrutinib) with a very low dose of radiation, aiming to control the disease effectively while minimizing side effects. The trial will enroll …
Matched conditions: LYMPHOMA, B-CELL MARGINAL ZONE
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC